Sichuan Goldstone Asia Pharmaceutical Inc. (300434.SZ) SHZ

9.68

-0.16(-1.63%)

Updated at June 03 10:07AM

Currency In CNY

Valuation

Market Cap4.1B
Enterprise Value3.86B
P/E Ratio21.09
PEG Ratio0.12
Price/Sales Ratio3.61
Price/Book Ratio1.46
Enterprise/Revenue3.39
Enterprise/EBITDA12.7

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.17
Operating Margin0.19

Management Effectiveness

Return On Assets0.06
Return On Equity0.07

Income Statement

Revenue1.04B
Revenue/Share2.68
Gross Profit605.23M
EBITDA257.4M
Net Income131.62M
Diluted EPS0.33

Balance Sheet

Total Cash337.45M
Total Cash/Share0.84
Total Debt68.59M
Total Debt/Equity0.03
Current Ratio2.9
Book Value Per Share6.69

Price History

52-Week Change-6.55
52-Week High13.56
52-Week Low8.95
Moving Average 50 Days10.65
Moving Average 200 Days10.67

Statistics

Average Volume10.9M
Shares Outstanding401.74M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.07
Trailing Annual Dividend Yield0.71
Payout Ratio0.15
Last Split Factor9:5
Last Split DateOctober 12, 2018